Company: BHM
Filing Date: 2025-10-08
Form Type: S-11
Source: 0001104659-25-097905
Chunk: 385

Company: Bluerock Homes Trust, Inc.
Filing Date: 2025-10-08
Form: S-11
Chunk 385
---
empt prohibited transactions, it is particularly important that fiduciaries, or other persons considering purchasing our Series B Redeemable Preferred Stock on behalf of, or with the assets of, any Plan, consult with their counsel regarding the potential applicability of ERISA, Section 4975 of the Code and any Similar Laws to such investment and whether an exemption would be applicable to the purchase and holding of our Series B Redeemable Preferred Stock. The acquisition, holding and, to the extent relevant, disposition of our Series B Redeemable Preferred Stock by or to any Plan is in no respect a representation by us or any of our affiliates or representatives that such an investment meets all relevant legal requirements with respect to investments by such Plans generally or any particular Plan, or that such an investment is appropriate for Plans generally or any particular Plan. Purchasers of our Series B Redeemable Preferred Stock have the exclusive responsibility for ensuring that their purchase and holding of our Series B Redeemable Preferred Stock complies with the fiduciary responsibility rules of ERISA and does not violate the prohibited transaction rules of ERISA, the Code or applicable Similar Laws.

<div align='center'>175

PLAN OF DISTRIBUTION</div>

General

We are offering a maximum
of 14,000,000 shares of our Series B Redeemable Preferred Stock in the offering through an affiliate of Bluerock, Bluerock Capital
Markets, LLC, our dealer manager, on a “best efforts” basis, which means that the dealer manager is only required to use its
good faith efforts and reasonable diligence to sell the Series B Redeemable Preferred Stock and has no firm commitment or obligation
to purchase any specific number or dollar amount of the Series B Redeemable Preferred Stock. Each share of Series B Redeemable
Preferred Stock will be sold at a public offering price of $25.00 per share. Selling commissions will not be payable in connection
with advisory transactions, and may be reduced or waived at the discretion of a participating broker-dealer. To the extent a participating
broker-dealer reduces its selling commissions below 7.0%, the net proceeds to us will not be affected by such reduction of the commissions
payable in connection with such sales, and the public offering price per share will be decreased by an amount equal to such reduction
as exemplified in the table below. Such reductions will have no effect on the amount of any distributions to be received by the investor,
nor on the amount of any fees to be paid by the investor